Brevan Howard Capital Management’s UiPath PATH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.9M Buy
261,461
+197,425
+308% +$2.51M 0.03% 421
2025
Q4
$1.05M Sell
64,036
-110,958
-63% -$1.73M 0.01% 742
2025
Q3
$2.34M Sell
174,994
-183,452
-51% -$2.17M 0.01% 492
2025
Q2
$4.59M Buy
+358,446
New +$4.3M 0.03% 392
2024
Q2
Sell
-14,944
Closed -$339K 1325
2024
Q1
$339K Sell
14,944
-3,161
-17% -$74K ﹤0.01% 605
2023
Q4
$450K Buy
18,105
+5,389
+42% +$105K 0.01% 528
2023
Q3
$218K Buy
+12,716
New +$212K ﹤0.01% 315

Other funds holding PATH

Brevan Howard Capital Management's PATH Position: Q1 2026 in Review

Brevan Howard Capital Management increased its UiPath (PATH) stake by 308% in Q1 2026, buying an estimated $2.51M and bringing the position to 261,461 shares worth $2.9M. The position accounts for 0.03% of the portfolio, ranked #421.

Brevan Howard Capital Management first reported a position in PATH in Q3 2023 and has held it in 7 quarters since. The position peaked at $4.59M in Q2 2025. 533 funds tracked by Wall St. Rank hold PATH as of Q1 2026.

  • Brevan Howard Capital Management held 261,461 shares of UiPath worth $2.9M as of Q1 2026.
  • Brevan Howard Capital Management bought 197,425 UiPath shares in Q1 2026, an estimated $2.51M.
  • UiPath made up 0.03% of Brevan Howard Capital Management's portfolio in Q1 2026, its #421 holding.
  • Brevan Howard Capital Management first reported a position in UiPath in Q3 2023 and has held it in 7 quarters since.
  • Brevan Howard Capital Management's UiPath position peaked at $4.59M in Q2 2025.
  • 533 funds tracked by Wall St. Rank held UiPath as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.